{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:13:53Z","timestamp":1778696033078,"version":"3.51.4"},"reference-count":23,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1517\/14656566.3.2.167","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T01:21:59Z","timestamp":1115256119000},"page":"167-172","source":"Crossref","is-referenced-by-count":22,"title":["The use of \u03b1-adrenoceptor antagonists in lower urinary tract disease"],"prefix":"10.1517","volume":"3","author":[{"given":"Russell","family":"Chess-Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00624726","volume":"352","author":"MICHEL MC","year":"1995","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacy]."},{"key":"CIT0002","first-page":"209","volume":"49","author":"FORD APDW, ARREDONDO NF, BLUE DR et al","year":"1996","journal-title":"Mal Pharmacy]"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-5793(98)00024-6","volume":"422","author":"CHANG DJ","year":"1998","journal-title":"FEBS Letters"},{"key":"CIT0004","first-page":"1127","volume":"121","author":"FORD APDW, DANIELS DV,","year":"1997","journal-title":"CHANG DJ etal.: Pharmacological pleiotropism of the human recombinant aucadrenoceptor: implications for aradrenoceptor classification. Br j Pharmacy]"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0014-2999(99)00154-5","volume":"370","author":"DANIELS DV","year":"1999","journal-title":"Eur. Pharmacy]."},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"BERRY SJ","year":"1984","journal-title":"j Ural."},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1464-410X.1975.tb03947.x","volume":"47","author":"CAINE M","year":"1975","journal-title":"Br .j Ural."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0022-5347(17)53216-4","volume":"128","author":"FURUYA S","year":"1982","journal-title":"j Ural."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1464-410X.1978.tb06210.x","volume":"50","author":"CAINE M","year":"1978","journal-title":"Br j Ural."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1476-5381.1995.tb15001.x","volume":"115","author":"MARSHALL I","year":"1995","journal-title":"Br I Pharmacal"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1994.tb17053.x","volume":"113","author":"HATANO A","year":"1994","journal-title":"Br I Pharmacal"},{"key":"CIT0015","first-page":"306","volume":"10","author":"CHAPPLE CR","year":"1991","journal-title":"Neural. Uradyn."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1476-5381.1996.tb16009.x","volume":"119","author":"CHESS-WILLIAMS R","year":"1996","journal-title":"Br. J. Pharmacy]."},{"issue":"1","key":"CIT0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/14656566.1.1.71","volume":"1","author":"TERPENING C","year":"1999","journal-title":"Expert Opin. Pharmacather."},{"key":"CIT0020","first-page":"764","volume":"51","author":"XIN X","year":"1997","journal-title":"Mal. Pharmacy]."},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(99)00271-X","volume":"374","author":"NISHIO E","year":"1999","journal-title":"Euri Pharmacal"},{"key":"CIT0022","first-page":"1810","volume":"159","author":"KYPRIANOU N","year":"1998","journal-title":"BORKOWSKI A etal.: Induction of prostatic apoptosis by doxazosin in benign prostatic hyperplasia. I Ural."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","volume":"338","author":"MCCONNELL JD","year":"1998","journal-title":"N Engl. Med."},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0090-4295(96)00504-3","volume":"49","author":"LEPOR H","year":"1997","journal-title":"Urology"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s001200050062","volume":"36","author":"HEIMBACH D","year":"1997","journal-title":"Uralage Ausgabe A."},{"key":"CIT0030","first-page":"937","volume":"160","author":"MALLOY BJ","year":"1998","journal-title":"I Ural."},{"key":"CIT0031","first-page":"414","volume":"13","author":"SMITH DJ","year":"1994","journal-title":"Neuraural Uradyn."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0169-328X(98)00287-3","volume":"63","author":"SMITH MS","year":"1999","journal-title":"Mal Brain Res."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.3.2.167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T23:28:14Z","timestamp":1550446094000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.3.2.167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,2,25]]},"published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1517\/14656566.3.2.167"],"URL":"https:\/\/doi.org\/10.1517\/14656566.3.2.167","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}